Literature DB >> 221541

Membrane fluidity in human and mouse Chediak-Higashi leukocytes.

R A Haak, L M Ingraham, R L Baehner, L A Boxer.   

Abstract

Polymorphonuclear leukocytes from humans and mice with the Chediak-Higashi syndrome were characterized by spin label electron spin resonance spectrometry. Our results suggest that cells from afflicted mice and humans have membranes more fluid than controls. Order parameters for a spin label that probes near the membrane surface were 0.652 for normals and 0.645 for two Chediak-Higashi patients. Cells from Chediak-Higashi mice showed similar differences, as did isolated plasma membrane fractions. An increased membrane fluidity was also detected with a spin label that probes deeper in the bilayer. In vitro treatment of Chediak-Higashi mouse cells with 0.01 M ascorbate increased the order parameter to normal levels. In vitro incubation of mouse Chediak-Higashi cells with glucose oxidase increased the order parameter, similar to the effect of ascorbate. This increase was abolished when catalase was added to the incubation medium. In vitro incubation with dibutyryl cyclic guanosine monophosphate (1 muM to 0.1 mM) did not normalize order parameters. These results indicate that fluidity of Chediak-Higashi cell membranes was affected by treatments expected to alter the oxidation: reduction potential of the environment but was not affected by treatments expected to alter the ratio of intracellular cyclic nucleotides. The latter treatment would affect microtubule assembly. Therefore, it appears that the membrane fluidity abnormalities as demonstrated by electron spin resonance and the earlier demonstrated microtubule dysfunctions characteristic of Chediak-Higashi cells are coexisting defects and are probably not directly related.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221541      PMCID: PMC372099          DOI: 10.1172/JCI109432

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  CHEDIAK-HIGASHI SYNDROME. CYTOLOGIC AND SERUM LIPID OBSERVATIONS IN A CASE AND FAMILY.

Authors:  R A KRITZLER; J Y TERNER; J LINDENBAUM; J MAGIDSON; R WILLIAMS; R PRESIG; G B PHILLIPS
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

2.  Methods for the study of surviving leukocytes: A. Preparation of cell suspension.

Authors:  S P MARTIN; R GREEN
Journal:  Methods Med Res       Date:  1958

3.  Role of microtubules in granulocyte adherence.

Authors:  L A Boxer; J M Allen; A M Watanabe; H R Besch; R L Baehner
Journal:  Blood       Date:  1978-06       Impact factor: 22.113

4.  Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy.

Authors:  B Sato; K Nishikida; L T Samuels; F H Tyler
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

5.  Large granules and lysosomal fusion in human Chediak-Higashi white blood cells.

Authors:  L A Rozenszajn; E B David; S B Sela
Journal:  Acta Haematol       Date:  1977       Impact factor: 2.195

6.  Immunocytochemical identification of azurophilic and specific granule markers in the giant granules of Chediak-Higashi neutrophils.

Authors:  P G Rausch; K B Pryzwansky; J K Spitznagel
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

7.  The increase of phospholipid bilayer rigidity after lipid peroxidation.

Authors:  G E Dobretsov; T A Borschevskaya; V A Petrov; Y A Vladimirov
Journal:  FEBS Lett       Date:  1977-12-01       Impact factor: 4.124

Review 8.  Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome.

Authors:  J M Oliver
Journal:  Am J Pathol       Date:  1976-11       Impact factor: 4.307

9.  Improvement of Chediak-Higashi leukocyte function by cyclic guanosine monophosphate.

Authors:  L A Boxer; M Rister; J M Allen; R L Baehner
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

10.  Correction of leukocyte function in Chediak-Higashi syndrome by ascorbate.

Authors:  L A Boxer; A M Watanabe; M Rister; H R Besch; J Allen; R L Baehner
Journal:  N Engl J Med       Date:  1976-11-04       Impact factor: 91.245

View more
  14 in total

1.  Chédiak-Higashi syndrome neutrophils are characterized by the absence of both normal azurophilic granules.

Authors:  B C West
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

Review 2.  The role of cytoskeletal and cytocontractile elements in pathologic processes.

Authors:  E Rungger-Brändle; G Gabbiani
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

3.  Interaction of chemotactic factors with human polymorphonuclear leukocytes: studies using a membrane potential-sensitive cyanine dye.

Authors:  B E Seligmann; E K Gallin; D L Martin; W Shain; J I Gallin
Journal:  J Membr Biol       Date:  1980       Impact factor: 1.843

4.  Steroids decrease granulocyte membrane fluidity, while phorbol ester increases membrane fluidity. Studies using electron paramagnetic resonance.

Authors:  H R Lamche; P T Silberstein; A C Knabe; D D Thomas; H S Jacob; D E Hammerschmidt
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

5.  Membrane-bound lactoferrin alters the surface properties of polymorphonuclear leukocytes.

Authors:  L A Boxer; R A Haak; H H Yang; J B Wolach; J A Whitcomb; C J Butterick; R L Baehner
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

6.  Ultrastructure of resting and activated storage pool deficient platelets from animals with the Chédiak-Higashi syndrome.

Authors:  K M Meyers; G Hopkins; H Holmsen; K Benson; D J Prieur
Journal:  Am J Pathol       Date:  1982-03       Impact factor: 4.307

7.  Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors.

Authors:  C Gardi; E Cavarra; P Calzoni; P Marcolongo; M de Santi; P A Martorana; G Lungarella
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

8.  Experimental and computational studies investigating trehalose protection of HepG2 cells from palmitate-induced toxicity.

Authors:  Sukit Leekumjorn; Yifei Wu; Amadeu K Sum; Christina Chan
Journal:  Biophys J       Date:  2007-12-20       Impact factor: 4.033

9.  The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR.

Authors:  Xu Hannah Zhang; Chunying Zhao; Zhongmin Alex Ma
Journal:  J Cell Sci       Date:  2007-12-01       Impact factor: 5.285

10.  Abnormalities of polymorphonuclear leukocyte function associated with a heritable deficiency of high molecular weight surface glycoproteins (GP138): common relationship to diminished cell adherence.

Authors:  D C Anderson; F C Schmalstieg; M A Arnaout; S Kohl; M F Tosi; N Dana; G J Buffone; B J Hughes; B R Brinkley; W D Dickey
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.